Senior Manager, Strategy & Transformation - Change Management

Senior Manager, Strategy & Transformation

Senior Manager of Strategy & Transformation at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, is responsible for leading, facilitating, and driving the strategic initiatives that increase growth, market share, and customer & employee satisfaction while improving key business performance indicators.

SCRI is a global oncology research organization committed to advancing therapies for cancer patients worldwide. unaware of the fight against cancer, the Senior Manager will lead a team of internal consultants and/or business analysts to implement enterprise‑level initiatives that support the organization’s strategic goals.

• Directly manage a team of Program Managers and Business Analysts leading high‑impact strategic initiatives across SCRI.
• Partner with the AVP of Strategy and Transformation to facilitate leadership in identifying, scheduling, and prioritizing initiatives, maintaining ongoing dialogue and ensuring timely resolution of issues.
• Introduce project‑management tools, templates, and techniques, coaching direct reports and delivery teams, coordinating cross‑department deliverables, and fostering open communication.
• Serve as the single point of contact for complex enterprise deployments, managing projects of significant complexity and tracking interrelated projects as programs.
• Oversee project‑management activities of direct reports, ensuring excellence in initiative management and proactive coaching.
• Establish and lead high‑visibility enterprise‑wide, табская strategies, including launching new products, systems integration, operational efficiency improvements, process reengineering, and infrastructure upgrades.
• Implement changes and manage impacted people through the change journey, communicating with internal and external stakeholders to ensure successful implementation and sustainment post‑project.
• Propose recommendations, adjustments, and process improvements to achieve success.

• Practice and adhere to the “Code of Conduct” philosophy and “Mission and Value Statement.”
• Complete any training assignments assigned by SCRI by their due dates.

• Change management and project‑management techniques and tools.
• Knowledge of the research environment and healthcare processes.
• Strong working relationship with leadership for rapid problem resolution and staff support.
• Experience leading enterprise‑wide strategic initiatives with large change impacts.

• Advanced facilitation and leadership skills, including written and oral communication and fostering collaboration.
• Interpersonal skills.
• Advanced analytic capabilities with six sigma methods and tools.
• Computer skills with proficiency in Microsoft Office (PowerPoint, Word, Projects, Excel).
• Strong people‑management skills to coach direct reports through these abilities.

• Quickly earn trust of sponsors and key stakeholders, lead and inspire teams, set direction, resolve conflict, and deliver tough messages with grace.
érences ... starters additional
• Persuasive, encouraging, motivating; communicate complex ideas simply.
• Navigate a highly matrixed organization effectively.
• Exhibit influencing and negotiating skills.
• Comfortable raising questions, objections, and ideas at all levels of the organization.

• Master's Degree required.
• 5+ years of experience in program management.
• 2+ years of experience in people management.
• Experience leading enterprise‑wide strategic initiatives with large change impacts.
• Six Sigma Green Belt or Six Sigma Black Belt highly preferred.

This role is hybridceased in Nashville, TN.

Interested candidates should submit their application through  Applications will be accepted through January 19, 2026. Please ensure all vehend required materials are included as outlined in the posting.

Sarah Cannon Research Institute (SCRI) is one of the world香蕉 leading oncology research organizations conducting community‑based clinical trials. Focused on advancing therapies for patients, SCRI is a leader in drug development. Since 2022, SCRI has expanded clinical trial access nationwide and has…